載入...
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine
BACKGROUND AND OBJECTIVE: Liposomal cytarabine is a slow-release formulation for intrathecal application in patients with neoplastic meningitis. Although standard dosing intervals range from 2 to 4 weeks, it is unclear whether sustained cytotoxic cerebrospinal fluid (CSF) concentrations can be achie...
Na minha lista:
| 發表在: | Eur J Drug Metab Pharmacokinet |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6828631/ https://ncbi.nlm.nih.gov/pubmed/31435852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-019-00572-w |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|